Private Equity

Updated:

Kerentech

Kerentech Consulting Ltd is based in Israel and has supported biotech and medtech businesses globally since 2004. The firm fundraises for medtech and biotech...

Kerentech logo

Kerentech

Kerentech Consulting Ltd is based in Israel and has supported biotech and medtech businesses globally since 2004. The firm fundraises for medtech and biotech companies, mediates cooperation across continents, and helps biotech, medtech, and pharma companies in-license and out-license know-how. It also works in technology transfer and investment advising, with a track record of helping 150+ businesses.

General information

Firm type

Private Equity

Year founded

2004

Location

Region

Middle East

Country

Israel

City

Jerusalem

Corporate office

Jerusalem, Israel

Sector focus

Enterprise SoftwareCybersecurityAI/MLIndustrial Tech

Frequently asked questions

What investment stages does Kerentech typically target?

Kerentech deploys across early-stage venture, co-investments, spin-offs, and PIPE transactions. This range allows the firm to commit at formation rounds and follow portfolio companies through later private financings. By spanning multiple entry points, Kerentech is not constrained to a single-stage mandate when technical founders evolve their capital needs from seed to pre-IPO.

How does Kerentech source proprietary deal flow?

Kerentech's Jerusalem base provides a structural sourcing advantage distinct from the Tel Aviv–Herzliya venture corridor. Proximity to Hebrew University's engineering and computer science faculties, together with Israel's defense-aligned R&D talent pool, creates a pipeline of technically dense startups. Competing investors often encounter these teams later, after they have already secured a local lead.

Does Kerentech participate in fund commitments or only direct deals?

The firm's disclosed strategy emphasizes direct investments — early-stage equity, co-investments, PIPE, and spin-offs — rather than fund-of-fund commitments. Kerentech's approach positions it as a balance-sheet investor alongside global venture syndicates, not a limited partner allocating to third-party managers.

How is Kerentech related to Israel's defense-technology ecosystem?

Many Israeli cybersecurity and enterprise-software founders emerge from intelligence units with deep technical training. Kerentech's early-stage posture and geographic position naturally place it in the orbit of those founders. The firm has not publicly disclosed formal ties to defense agencies or state-backed R&D programs, but the gravitational effect of Israel's defense-to-startup pipeline is a feature of its sourcing environment.

Profile maintained by using OSINT (open-source intelligence), regulatory filings, licensed data partners, and verified direct submissions. Read the methodology. Last updated: . Continuous refresh with full update cycles at least every 30 days.

Need institutional-grade insight on private equity firms?

Altss delivers:

Principals with verified direct contactsAllocation history by asset classOSINT-derived deal signals
Book a demo

Prefer a guided tour?

We’ll walk you through:

Interactive funding timelinesCustom mandate & allocation filters
Book a demo

Browse by category

More Jerusalem Private Equity profiles